CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 3,406,057
- Share change
- -275,213
- Total reported value
- $10,626,381
- Put/Call ratio
- 86%
- Price per share
- $3.12
- Number of holders
- 30
- Value change
- -$866,501
- Number of buys
- 9
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
13F
|
Company |
4.9%
|
730,932
|
$3,545,020 | $0 | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
5.1%
|
775,976
|
$2,599,520 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.3%
|
494,963
|
$1,658,126 | — | 30 Jun 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
— |
4%
|
598,634
|
$1,618,467 | -$571,171 | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
411,786
|
$1,379,483 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.7%
|
252,889
|
$847,178 | — | 30 Jun 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
1.5%
|
220,707
|
$739,368 | — | 30 Jun 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
188,355
|
$630,989 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
180,229
|
$603,767 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
100,237
|
$335,838 | — | 30 Jun 2025 | |
| Martin E. Cearnal |
3/4/5
|
Sr VP/Chief Commercial Officer, Director |
—
class O/S missing
|
163,473
|
$277,904 | — | 17 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.49%
|
74,406
|
$249,260 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.48%
|
72,513
|
$242,918 | — | 30 Jun 2025 | |
| Leo Pavliv |
3/4/5
|
SVP and Chief Development Off. |
—
class O/S missing
|
129,618
|
$220,351 | — | 31 May 2022 | |
| BlackRock, Inc. |
13F
|
Company |
0.34%
|
51,168
|
$171,413 | — | 30 Jun 2025 | |
| Joey A. Jacobs |
3/4/5
|
Director |
—
class O/S missing
|
98,415
|
$167,306 | — | 14 Jan 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.29%
|
44,288
|
$148,000 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
33,700
|
$112,895 | — | 30 Jun 2025 | |
| Heron Bay Capital Management |
13F
|
Company |
0.22%
|
33,251
|
$111,391 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
32,265
|
$108,088 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.13%
|
19,603
|
$65,670 | — | 30 Jun 2025 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.12%
|
18,475
|
$61,891 | — | 30 Jun 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.09%
|
14,218
|
$47,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
12,398
|
$41,533 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
11,527
|
$38,615 | — | 30 Jun 2025 | |
| &PARTNERS |
13F
|
Company |
0.07%
|
11,000
|
$36,850 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.07%
|
10,280
|
$34,438 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
8,818
|
$29,540 | — | 30 Jun 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.05%
|
8,222
|
$27,544 | — | 30 Jun 2025 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
2,102
|
$7,042 | — | 30 Jun 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.01%
|
1,428
|
$4,783 | — | 30 Jun 2025 | |
| Capital Advisors, Ltd. LLC |
13F
|
Company |
0%
|
437
|
$1,000 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
94
|
$315 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
2
|
$7 | — | 30 Jun 2025 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Jun 2025 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q3 2025
As of 30 Sep 2025,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,406,057 shares.
The largest 10 holders included
MILLENNIUM MANAGEMENT LLC, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, J. Goldman & Co LP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and Bank of New York Mellon Corp.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
30
Q3 2025 holders
30
Holder diff
0
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.